CPT® Code 86717

1. Indications

The antibody test for Leishmania (CPT® Code 86717) is indicated for the following conditions:

• Suspected Leishmaniasis Infection The test is performed when there is a clinical suspicion of Leishmaniasis, particularly in patients who have traveled to endemic regions or have been exposed to sand flies.
• Evaluation of Symptoms It is indicated for patients presenting with symptoms such as skin sores, ulcers, fever, weight loss, or splenomegaly, which may suggest either cutaneous or visceral forms of the disease.
• Monitoring Disease Progression The test may be used to monitor the immune response in patients diagnosed with Leishmaniasis, helping to assess the effectiveness of treatment.

2. Procedure

The procedure for conducting the Leishmania antibody test involves several key steps:

• Step 1: Patient Preparation Prior to the test, the patient may be instructed to avoid certain medications or supplements that could interfere with the test results. It is essential to ensure that the patient is adequately informed about the procedure and its purpose.
• Step 2: Venipuncture A qualified healthcare professional performs venipuncture to obtain a blood sample from the patient. This involves using a sterile needle to puncture a vein, typically in the arm, and collecting the blood into a designated collection tube. The procedure is performed under aseptic conditions to minimize the risk of infection.
• Step 3: Serum Separation After the blood sample is collected, it is processed in the laboratory to separate the serum from the cellular components. This is typically done by centrifugation, which spins the sample at high speeds to separate the liquid serum from the blood cells.
• Step 4: Immunoassay Testing The serum is then subjected to a semi-quantitative immunoassay, which detects the presence of IgG antibodies specific to Leishmania. This assay measures the concentration of antibodies, providing insight into the patient's immune response to the infection.
• Step 5: Result Interpretation Once the testing is complete, the results are analyzed and interpreted by a qualified laboratory professional. A positive result indicates the presence of antibodies, suggesting current or past infection with Leishmania.

3. Post-Procedure

After the procedure, patients may experience minor discomfort or bruising at the venipuncture site, which typically resolves quickly. There are no specific post-procedure care instructions required for this test, but patients should be advised to report any unusual symptoms or prolonged discomfort. The results of the test will be communicated to the healthcare provider, who will discuss the findings with the patient and determine any necessary follow-up actions or treatments based on the results.